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Morpholino oligonucleotides (MO) are commonly used to reduce gene expression.  MO 
selectivity is determined by selection of a unique oligonucleotide sequence in the target 
of interest  Suitable targets for splice altering MO are at an intron-exon junction in pre 
messenger RNA. The MO is predicted to anneal to the complimentary sequence and to 
inhibit intron-exon splicing.  However, it is possible that an MO may anneal to an un-
identified target(s) resulting in a phenotype that is unrelated to the gene of interest.  
Therefore it is necessary to validate MO efficacy on the targeted gene. This objective for 
this project is to validate anoctamin 1 splice-altering MO efficacy in zebrafish.  
Quantitative polymerase chain reaction (Q-PCR) will be used to compare anoctamin 1 
expression levels in non-injected control embryos and in MO-injected embryos at 2 and 5 
days post fertilization. Anoctamin 1 splice altering MO was designed to excise exon 4.  
We predict that MO knockdown will be greater at 2 dpf compared to 5 dpf.  Data will be 
presented validating primer design and efficacy. This work will contribute to a better 
understanding of the general MO mechanism of action and will also validate an important 
technique to study anoctamin 1 function in zebrafish.   
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